Clostridium difficile-associated diarrhoea in hospitalised patients

Journal of Clinical Pharmacy and Therapeutics

Volumn 25, Issue 2, 2000, Pages 101-109

  Al Eidan, F A ^c   McElnay, J C ^b   Scott, M G ^c   Kearney, M P ^a  

^a United Hospital Group Trust   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; CEFALEXIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; ERYTHROMYCIN; FLUCLOXACILLIN; GENTAMICIN; METRONIDAZOLE; PENICILLIN G; TRIMETHOPRIM; VANCOMYCIN;

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL FEATURE; CLOSTRIDIUM DIFFICILE; COMORBIDITY; DIARRHEA; DRUG EFFICACY; FEMALE; FEVER; GASTROINTESTINAL ENDOSCOPY; HEALTH CARE COST; HOSPITAL PATIENT; HUMAN; INCIDENCE; LEUKOCYTOSIS; MAJOR CLINICAL STUDY; MALE; NURSING HOME; PSEUDOMEMBRANOUS COLITIS; RETROSPECTIVE STUDY; RISK FACTOR; SEX RATIO;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CEPHALOSPORINS; CLOSTRIDIUM DIFFICILE; COSTS AND COST ANALYSIS; CROSS INFECTION; DIARRHEA; DRUG COSTS; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; NURSING HOMES; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 0034072716     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.2000.00266.x     Document Type: Article

References (48)

1. 1. Finney JMT. (1893) Gastroenterostomy for cicatrizing ulcer of the pylorus. Johns Hopkins Hospital Bulletin, 4, 53-55.
2. 2. Hall IC, O'Toole E. (1935) Intestinal flora in new-born infants with a description of a new pathogenic anaerobe Bacillus difficilis. American Journal of Diseases of Children, 49, 390-402.
3. 3. Larson HE, Parry JV, Price AB, Davies DR, Dolby J, Tyrrell DAJ. (1977) Undescribed toxin in pseudomembranous colitis. British Medical Journal, 1, 1246-1248.
4. 4. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. (1978) Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. New England Journal of Medicine, 298, 531-534.
5. 5. Mitty RD, Lamont JT. (1994) Clostridium difficile: epidemiology, pathology and treatment. Mount Sinai Journal of Medicine, 61, 329-335.
6. 6. Bartlett JG. (1979) Antibiotic-associated pseudomembranous colitis. Reviews of Infectious Diseases, 1, 530-539.
7. 7. Silva J, Fekety R, Werk C, et al. (1984) Inciting and etiologic agents of colitis. Reviews of Infectious Diseases, 6(Suppl. 1), 214-221.
8. 8. McFarland LV, Surawicz CM, Stamm WE. (1990) Risk factors for Clostridium difficile carriage and Clostridium difficile-associated diarrhoea in a cohort of hospitalized patients. Journal of Infectious Diseases, 162, 678-684.
9. 9. Colarian J. (1988) Clostridium difficile colitis following antiviral therapy in the acquired immunodeficiency syndrome. American Journal of Medicine, 84, 1081.
10. 10. Thomson G, Clark AH, Hare K, Spilg WGS. (1981) Pseudomembranous colitis after treatment with metronidazole. British Medical Journal, 282, 964-965.
11. 11. Saginur R, Hawley CR, Bartlett JG. (1980) Colitis associated with metronidazole therapy. Journal of Infectious Diseases, 141, 772-774.
12. 12. Miller SN, Ringler RP. (1987) Vancomycin-induced pseudomembranous colitis. Journal of Clinical Gastroenterology, 9, 114-115.
13. 13. McNeeley SG, Anderson GD, Sibai BM. (1985) Clostridium difficile colitis associated with single-dose cefazolin prophylaxis. Obstetrics and Gynaecology, 66, 737-738.
14. 14. Privitera G, Scarpellini P, Ortisi G, Nicastro G, de Nicolin R, Lalla F. (1991) Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery. Antimicrobial Agents and Chemotherapy, 35, 208-210.
15. 15. Reinke CM, Messick CR. (1994) Update on Clostridium difficile-induced colitis, part 1. American Journal of Hospital Pharmacy, 51, 1771-1781.
16. 16. Silva J. (1989) Update on pseudomembranous colitis. Western Journal of Medicine, 151, 644-648.
17. 17. Anand A, Glatt AE. (1993) Clostridium difficile infection associated with antineoplastic chemotherapy: a review. Clinical Infectious Diseases, 17, 109-113.
18. 18. Kamthan AG, Bruckner HW, Hirschman SZ, Agus SG. (1992) Clostridium difficile diarroea induced by cancer chemotherapy. Archives of Internal Medicine, 152, 1715-1717.
19. 19. Bennett RG, Greenough WB. (1990) Clostridium difficile diarrhoea: a common and overlooked nursing home infection. Geriatrics, 45, 77-87.
20. 20. Simor AE, Yake SL, Tsimidis K. (1993) Infection due to Clostridium difficile among elderly residents of a long term-care facility. Clinical Infectious Diseases, 17, 672-678.
21. 21. Heard SR, Wren B, Barnett MJ, Thomas JM, Tabaqchali S. (1988) Clostridium difficile infection in patients with haematological malignant disease. Epidemiology and Infection, 100, 63-72.
22. 22. Cuuzzolin L, Zambreri D, Donini M, Griso C, Benoni G. (1992) Influence of radiotherapy on intestinal microflora in cancer patients. Journal of Chemotherapy, 4, 176-179.
23. 23. Bender BS, Bennett R, Laughon EB, et al. (1986) Is Clostridium difficile endemic in chronic-care facilities? Lancet, 2, 11-13.
24. 24. Teasley DG, Gerding DN, Olson MM, et al. (1983) Prospective randomised trial of metronidazole versus vancomycin for Clostridium difficile-associated diarrhoea and colitis. Lancet, ii, 1043-1046.
25. 25. Wilcox MH, Spencer RC. (1992) Clostridium difficile infection: response, relapses and re-infections. Journal of Hospital Infection, 22, 85-92.
26. 26. World Health Organisation (1996) Anatomical Therapeutic (ATC) Classification Index. Collaborating Centre for Drug Statistics Methodology, Oslo.
27. 27. Riley TV, O'Neill GL, Bowman RA, Golledge CL. (1994) Clostridium difficile-associated diarrhoea: epidemiological data from Western Australia. Epidemiology and Infection, 113, 13-20.
28. 28. Department of Health/Public Health Laboratory Service Joint Working Group. (1994) Report. The Prevention and Management of Clostridium difficile Infection. HMSO, London.
29. 29. Anand A, Bashey B, Mir T, Glatt AE. (1994) Epidemiology, clinical manifestation, and outcome of Clostridium difficile-associated diarrhoea. American Journal of Gastroenterology, 89, 519-523.
30. 30. Brown E, Talbot GH, Axelrod P, Provencher M, Hoegg C. (1990) Risk factors for Clostridium difficile toxin-associated diarrhoea. Infection Control and Hospital Epidemiology, 11, 283-290.
31. 31. Golledge CL, McKenzie T, Riley TV. (1989) Extended spectrum cephalosporins and Clostridium difficile. Journal of Antimicrobial Chemotherapy, 23, 929-931.
32. 32. Bartlett JG. (1992) Antibiotic-associated diarrhoea. Clinical Infectious Diseases, 15, 573-581.
33. 33. Jobe BA, Grasley A, Deveney KE, Deveney CW, Sheppard BC. (1995) Clostridium difficile colitis: an increasing hospital-acquired illness. American Journal of Surgery, 169, 480-483.
34. 34. Fekety R, Shah AB. (1993) Diagnosis and treatment of Clostridium difficile colitis. Journal of the American Medical Association, 269, 71-75.
35. 35. Hooker KD, DiPiro JT. (1988) Effect of antimicrobial therapy on bowel flora. Clinical Pharmacy, 7, 878-888.
36. 36. Tedesco FJ. (1977) Clindamycin and colitis: a review. Journal of Infectious Diseases, 135(Suppl.), 95-98.
37. 37. Impallomeni M, Galltly NP, Wort SJ, Starr JM, Rogers TR. (1995) Increased risk of diarrhoea caused by Clostridium difficile in elderly patients receiving cefotaxime. British Medical Journal, 311, 1345-1346.
38. 38. Pear SM, Williamson TH, Bettin KM, Gerding DN, Galgiani JN. (1994) Decrease in nosocomial Clostridium difficile-associated diarrhoea by restricting clindamycin use. Annals of Internal Medicine, 120, 272-277.
39. 39. Riley TV. (1996) Antibiotic-associated diarrhoea: a costly problem. Pharmacoeconomics, 10, 1-3.
40. 40. Macgowan AP, Brown I, Feeney R, et al. (1995) Clostridium difficile-associated diarrhoea and length of hospital stay. Journal of Hospital Infection, 31, 241-244.
41. 41. Riley TV, Codde JP, Rouse IL. (1995) Increased length of hospital stay due to Clostridium difficile-associated diarrhoea. Lancet, 345, 455-456.
42. 42. Wilcox MH, Howe R. (1995) Diarrhoea caused by Clostridium difficile: response time for treatment with metronidazole and vancomycin. Journal of Antimicrobial Chemotherapy, 36, 673-679.
43. 43. Kofsky P, Rosen L, Reed J, Tolmie M, Ufberg D. (1991) Clostridium difficile - a common and costly colitis. Disease of the Colon and Rectum, 34, 244-248.
44. 44. Marts BC, Longo WE, Vernava AM, Kennedy DJ, Daniel GL, Jones I. (1994) Patterns and prognosis of Clostridium difficile colitis. Disease of the Colon and Rectum, 37, 837-845.
45. 45. Ramaswamy R, Grover H, Corpuz M, Daniels P, Pitchumoni CS. (1996) Prognostic criteria in Clostridium difficile colitis. American Journal of Gastroenterology, 91, 460-464.
46. 46. McNulty C, Logan M, Donald IP, et al. (1997) Successful control of Clostridium difficile infection in an elderly care unit through use of a restrictive antibiotic policy. Journal of Antimicrobial Chemotherapy, 40, 707-711.
47. 47. Spencer RC. (1998) The role of antimicrobial agents in the aetiology of Clostridium difficile-associated disease. Journal of Antimicrobial Chemotherapy, 41(Suppl. C), 21-27.
48. 48. Gorbach SL. (1999) Antibiotics and Clostridium difficile. The New England Journal of Medicine, 341, 1690-1691.